Picture of Todos Medical logo

TOMDF Todos Medical Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m-99.03%
3m-3.21%
6m-7.3%
1yr-99.84%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-99.83%
50d MA-90.42%
200d MA-99.61%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-87218.75%
Return on Equityn/a
Operating Margin-129.83%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Todos Medical EPS forecast chart

Profile Summary

Todos Medical Ltd is a Israel-based clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer. The Companys Total Biochemical Infrared Analysis (TBIA) platform, represents a method for cancer screening of solid tumors using peripheral blood spectroscopy analysis. The process involves observing the immune system’s response to tumor presence. TBIA analyzes the entire biochemical signatures spectrum including proteins, lipids, nucleic acids and carbohydrates of effected immune cells from peripheral blood, using infrared spectroscopy.

Directors

    Last Annual
    December 31st, 2021
    Last Interim
    September 30th, 2022
    Incorporated
    April 22nd, 2010
    Public Since
    February 21st, 2017
    No. of Employees
    7
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    us flag iconPink Sheets on Nasdaq
    Shares in Issue
    2,130,423,853

    TOMDF Share Price Performance

    Upcoming Events for TOMDF

    Similar to TOMDF

    Picture of Actavia Life Sciences logo

    Actavia Life Sciences

    us flag iconPink Sheets on Nasdaq

    Picture of Acura Pharmaceuticals logo

    Acura Pharmaceuticals

    us flag iconPink Sheets on Nasdaq

    Picture of Adhera Therapeutics logo

    Adhera Therapeutics

    us flag iconPink Sheets on Nasdaq

    Picture of Ramoil Management logo

    Ramoil Management

    us flag iconPink Sheets on Nasdaq

    Picture of Adynxx logo

    Adynxx

    us flag iconPink Sheets on Nasdaq

    FAQ